Quantcast

Latest FDA Stories

2014-08-14 12:27:46

CoreValve® System Now Available to More U.S. Patients than any Other Transcatheter Aortic Valve MOUNTAIN VIEW, Calif., Aug. 14, 2014 /PRNewswire/ -- El Camino Hospital became one of the first hospitals in California to adopt a new minimally invasive system to treat patients with narrowed, failing aortic heart valves who are considered to be at high risk to undergo surgery. The U.S. Food and Drug Administration (FDA) approved the Medtronic CoreValve(®) System to treat patients with...

2014-08-13 23:09:49

On August 7, the US FDA informed consumers that two lots of RegeneSlim appetite control capsules, by Regeneca Worldwide, were recalled due to presence of DMAA. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 13, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on appetite control capsules. The FDA...

2014-08-13 23:04:32

NuMale Medical Center, a nationwide leader in men’s sexual health and enhancement, opened a new facility today in Albuquerque, New Mexico. Under the expert guidance of Chief Medical Officer Dr. Christopher Asandra, M.D, NuMale offers innovative, safe, FDA-Approved treatments for a host of men’s health issues, including erectile dysfunction, low testosterone, anti-aging treatments and NeoGraft Hair Transplant. Albuquerque, NM (PRWEB) August 13, 2014 A leading national provider of...

2014-08-13 12:29:00

TMJ NextGeneration(TM) hollow ear canal inserts are safe and effective alternatives to bite splints FARMINGTON HILLS, Mich., Aug. 13, 2014 /PRNewswire/ -- TMJ Health, LLC, today announced that TMJ NextGeneration(TM), a first-of-its-kind, FDA cleared medical device that is a safe and effective aid in reducing Temporomandibular Joint Disorder (TMJD) pain, is available nationwide. The device consists of two custom-made, hollow ear canal inserts that allow full passage of sound and are...

2014-08-13 12:28:06

An Intravenous Fat Emulsion Approved for Adult and Pediatric Patients BETHLEHEM, Pa., Aug. 13, 2014 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, announced today that it has received U.S. Food and Drug Administration (FDA) approval of Nutrilipid(®) 20% (I.V. fat emulsion) for parenteral nutrition therapy in adult & pediatric patients. Nutrilipid 20% is indicated as a source of calories and essential fatty acids for parenteral...

2014-08-12 23:12:21

Compelling new data on what consumers don't know about dental mercury and who's responsible for this major gap in patient awareness. Washington, DC (PRWEB) August 12, 2014 After decades of hearing their mercury-based dental fillings called “silver” and “amalgam” by their dentists and the FDA, it shouldn’t be surprising that Americans are feeling more than a little misled about what’s being put in their mouths. A new report released today by Consumers for Dental Choice,...

2014-08-12 23:10:30

On August 9, Cubist Pharmaceuticals, Inc. announced the recall of certain lots of Cubicin (daptomycin for injection) 500 mg due to the presence of particulate matter. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 12, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Cubicin (daptomycin for...

2014-08-12 08:31:32

Innovative OncoSolutions to Distribute Leading Closed System Transfer Devices in Canada; Announcement Comes Shortly After FDA Clears Device under ONB Product Code PORT WASHINGTON, New York and OAKVILLE, Ontario, August 12, 2014 /PRNewswire/ -- Equashield (http://www.equashield.com), a leading provider of Closed System Transfer Device [http://www.equashield.com ]s (CSTDs) for hazardous drugs, announced today a new exclusive partnership with Canadian distributor Innovative...

2014-08-12 08:29:37

First time in history a technology receives FDA approval and proposed national coverage by CMS on the same day MADISON, Wis., Aug. 12, 2014 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company's noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been...

2014-08-12 08:29:19

BEMA Buprenorphine on track for late 2014 or early 2015 NDA filing by partner Endo Pharmaceuticals RALEIGH, N.C., Aug. 12, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that along with its commercial partner, Endo Pharmaceuticals, engaged in a positive pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) regarding BEMA Buprenorphine for the management of pain severe enough to require daily, around-the-clock,...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related